Bristol-Myers Squibb Settles MDRP Underpayment Claim For $75 Million
By EsqSocial Corporation 15/04/21
The U.S. Department of Justice recently announced that Bristol-Myers Squibb (BMS) agreed to pay $75 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid Drug Rebate Program (MDRP). Of that total, $41 million plus interest will be paid to the federal government and the remainder to various state Medicaid programs......
By: Rivkin Radler LLP